GE Aerospace Receives Order for GEnx Engines From Eva Air-March 2024-www.financetom.com

GE Aerospace Receives Order for GEnx Engines From Eva Air

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

GE Aerospace Receives Order for GEnx Engines From Eva Air

Jul 24, 2024 8:13 AM

10:47 AM EDT, 07/24/2024 (MT Newswires) -- GE Aerospace (GE) said Wednesday that Eva Air has placed an order for GEnx engines following the airline's recent deal to acquire four Boeing ( BA ) 787-10 Dreamliner jets.

Financial terms of the order weren't disclosed.

GE Aerospace shares were down 1.5% in recent trading.

Price: 169.51, Change: -2.49, Percent Change: -1.45

Previous page： Why Branded Footwear Retailer Genesco's Shares Are Tumbling Today Next page： Shockwave Medical Insider Sold Shares Worth $507,294, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Why Branded Footwear Retailer Genesco's Shares Are Tumbling Today

Mar 8, 2024

Genesco Inc shares are plummeting after reporting fourth-quarter FY24 sales growth of 2% year-on-year to $738.95 million, beating the analyst consensus estimate of $705.66 million. Excluding the 14th week, sales would have decreased 2% for the fourth quarter of fiscal 2024. Total comparable sales declined 4%. Overall sales dropped 2% at Journeys, grew 6% at Schuh, up 9% at Johnston & Murphy,...

Shockwave Medical Insider Sold Shares Worth $507,294, According to a Recent SEC Filing

Mar 8, 2024

08:00 AM EST, 03/08/2024 (MT Newswires) -- Frank T Watkins, Director, on March 06, 2024, sold 2,000 shares in Shockwave Medical ( SWAV ) for $507,294. Following the Form 4 filing with the SEC, Watkins has control over a total of 4,532 shares of the company, with 4,532 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1642545/000164254524000075/xslF345X03/wk-form4_1709864771.xml Price: 261.95, Change: +5.84, Percent Change:...

Novo Nordisk confident of amycretin obesity drug launch this decade

Mar 8, 2024

BAGSVAERD, Denmark (Reuters) - Novo Nordisk is very comfortable it will be able to launch the pill version of its experimental weight loss drug amycretin this decade, the drugmaker's head of development told Reuters on Friday, a day after it announced strong early trial data on it. I never commit to timelines but I would be very comfortable to say...

Ani Pharmaceuticals Insider Sold Shares Worth $2,630,864, According to a Recent SEC Filing

Mar 8, 2024

08:09 AM EST, 03/08/2024 (MT Newswires) -- Muthusamy Shanmugam, Director, HEAD OF R&D, COO-NOVITIUM OPS, around March 05, 2024, sold 40,000 shares in Ani Pharmaceuticals ( ANIP ) for $2,630,864. Following the Form 4 filing with the SEC, Shanmugam has control over a total of 916,272 shares of the company, with 68,652 shares held directly and 847,620 shares controlled indirectly....